T-cell responses against Malaria: Effect of parasite antigen diversity and relevance for vaccine development.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Vaccine

• Publication date

  2018-04-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2018.03.023PMID 29573877
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sterile protection against human malaria by chemoattenuated PfSPZ vaccine

  2017cited by this paper
• Protection against Plasmodium falciparum malaria by PfSPZ Vaccine.

  2017cited by this paper
• Development of whole sporozoite malaria vaccines

  2017cited by this paper
• Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection

  2017cited by this paper
• Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial.

  2017cited by this paper
• Production, Quality Control, Stability and Pharmacotoxicity of a Malaria Vaccine Comprising Three Highly Similar PfAMA1 Protein Molecules to Overcome Antigenic Variation

  2016cited by this paper
• Gapped sequence alignment using artificial neural networks: application to the MHC class I system

  2016cited by this paper
• Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

  2016cited by this paper
• Human CD8+ T cells mediate protective immunity induced by a human malaria vaccine in human immune system mice

  2016cited by this paper
• Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children.

  2016cited by this paper
• Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes

  2016cited by this paper
• RTS,S: Toward a first landmark on the Malaria Vaccine Technology Roadmap.

  2015cited by this paper
• In Vivo Approaches Reveal a Key Role for DCs in CD4+ T Cell Activation and Parasite Clearance during the Acute Phase of Experimental Blood-Stage Malaria

  2015cited by this paper
• Lymph-Node Resident CD8α+ Dendritic Cells Capture Antigens from Migratory Malaria Sporozoites and Induce CD8+ T Cell Responses

  2015cited by this paper
• Longitudinal analysis of Plasmodium sporozoite motility in the dermis reveals component of blood vessel recognition

  2015cited by this paper
• Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine.

  2015cited by this paper
• Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.

  2015cited by this paper
• Development of an In Vitro Assay and Demonstration of Plasmodium berghei Liver-Stage Inhibition by TRAP-Specific CD8+ T Cells

  2015cited by this paper
• Antibody and B cell responses to Plasmodium sporozoites

  2014cited by this paper
• Severe Malaria

  2014cited by this paper
• Sterile Immunity to Malaria after DNA Prime/Adenovirus Boost Immunization Is Associated with Effector Memory CD8+T Cells Targeting AMA1 Class I Epitopes

  2014cited by this paper
• Controlled human malaria infection.

  2014cited by this paper
• Overcoming Antigenic Diversity by Enhancing the Immunogenicity of Conserved Epitopes on the Malaria Vaccine Candidate Apical Membrane Antigen-1

  2013cited by this paper
• DNA Prime/Adenovirus Boost Malaria Vaccine Encoding P. falciparum CSP and AMA1 Induces Sterile Protection Associated with Cell-Mediated Immunity

  2013cited by this paper
• Diversity of T Cell Epitopes in Plasmodium falciparum Circumsporozoite Protein Likely Due to Protein-Protein Interactions

  2013cited by this paper
• Role of host cell traversal by the malaria sporozoite during liver infection

  2013cited by this paper
• Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications.

  2013cited by this paper
• Controlled Human Malaria Infections by Intradermal Injection of Cryopreserved Plasmodium falciparum Sporozoites

  2013cited by this paper
• In vivo imaging of CD8+ T cell-mediated elimination of malaria liver stages

  2013cited by this paper
• The Relationship between RTS,S Vaccine-Induced Antibodies, CD4+ T Cell Responses and Protection against Plasmodium falciparum Infection

  2013cited by this paper
• Human host-derived cytokines associated with Plasmodium vivax transmission from acute malaria patients to Anopheles darlingi mosquitoes in the Peruvian Amazon.

  2013cited by this paper
• Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine

  2013cited by this paper
• Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity

  2013cited by this paper
• CD8+ T Cells Specific for a Malaria Cytoplasmic Antigen Form Clusters around Infected Hepatocytes and Are Protective at the Liver Stage of Infection

  2013cited by this paper
• Protective CD8+ T lymphocytes in Primates Immunized with Malaria Sporozoites

  2012cited by this paper
• Regulation of innate CD8+ T-cell activation mediated by cytokines

  2012cited by this paper
• A review of malaria vaccine clinical projects based on the WHO rainbow table

  2012cited by this paper
• Humoral Immune Responses to a Single Allele PfAMA1 Vaccine in Healthy Malaria-Naïve Adults

  2012cited by this paper
• Protective Immunity Induced with the RTS,S/AS Vaccine Is Associated with IL-2 and TNF-α Producing Effector and Central Memory CD4+ T Cells

  2011cited by this paper
• Immunization with the RTS,S/AS malaria vaccine induces IFN-γ(+)CD4 T cells that recognize only discrete regions of the circumsporozoite protein and these specificities are maintained following booster immunizations and challenge.

  2011cited by this paper
• Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and Tanzania: a randomised controlled trial

  2011cited by this paper
• Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study.

  2011cited by this paper
• Induction and maintenance of protective CD8+ T cells against malaria liver stages: implications for vaccine development.

  2011cited by this paper
• Live Attenuated Malaria Vaccine Designed to Protect Through Hepatic CD8+ T Cell Immunity

  2011cited by this paper
• Memories that last forever: strategies for optimizing vaccine T-cell memory.

  2010cited by this paper
• Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria

  2010cited by this paper
• Generation of Humoral Immune Responses to Multi-Allele PfAMA1 Vaccines; Effect of Adjuvant and Number of Component Alleles on the Breadth of Response

  2010cited by this paper
• Prolonged Antigen Presentation Is Required for Optimal CD8+ T Cell Responses against Malaria Liver Stage Parasites

  2010cited by this paper
• Genetically Attenuated Parasite Vaccines Induce Contact-Dependent CD8+ T Cell Killing of Plasmodium yoelii Liver Stage-Infected Hepatocytes1

  2009cited by this paper
• Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data

  2009cited by this paper
• Humoral Immune Response to Mixed PfAMA1 Alleles; Multivalent PfAMA1 Vaccines Induce Broad Specificity

  2009cited by this paper
• Protection against a malaria challenge by sporozoite inoculation.

  2009cited by this paper
• Extreme Polymorphism in a Vaccine Antigen and Risk of Clinical Malaria: Implications for Vaccine Development

  2009cited by this paper
• Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming ‘vaccine resistant malaria’

  2009cited by this paper
• Acquired Immunity to Malaria

  2009cited by this paper
• Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection.

  2009cited by this paper
• Kinetics of Mosquito-Injected Plasmodium Sporozoites in Mice: Fewer Sporozoites Are Injected into Sporozoite-Immunized Mice

  2009cited by this paper
• Knowlesi malaria: newly emergent and of public health importance?

  2008cited by this paper
• Plasmodium berghei-Infected Primary Hepatocytes Process and Present the Circumsporozoite Protein to Specific CD8+ T Cells In Vitro1

  2007cited by this paper
• Plasmodium sporozoites trickle out of the injection site

  2007cited by this paper
• Allele Specificity of Naturally Acquired Antibody Responses against Plasmodium falciparum Apical Membrane Antigen 1

  2005cited by this paper
• Dendritic Cells Induce Immunity and Long-Lasting Protection against Blood-Stage Malaria despite an In Vitro Parasite-Induced Maturation Defect

  2004cited by this paper
• Protective Immunity Induced with Malaria Vaccine, RTS,S, Is Linked to Plasmodium falciparum Circumsporozoite Protein-Specific CD4+ and CD8+ T Cells Producing IFN-γ1

  2003cited by this paper
• World Health Organization,

  2003cited by this paper
• T cells as mediators of protective immunity against liver stages of Plasmodium.

  2003cited by this paper
• Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum.

  2002cited by this paper
• Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites.

  2002cited by this paper
• In Vitro Studies with Recombinant Plasmodium falciparum Apical Membrane Antigen 1 (AMA1): Production and Activity of an AMA1 Vaccine and Generation of a Multiallelic Response

  2002cited by this paper
• A Subdominant CD8+ Cytotoxic T Lymphocyte (CTL) Epitope from the Plasmodium yoeliiCircumsporozoite Protein Induces CTLs That Eliminate Infected Hepatocytes from Culture

  2000cited by this paper
• γδ+ T Cells Preferentially Respond to Live Rather than Killed Malaria Parasites

  1998cited by this paper
• Human and murine T‐cell responses to allelic forms of a malaria circumsporozoite protein epitope support a polyvalent vaccine strategy

  1998cited by this paper
• Polyclonal T‐cell responses to Plasmodium falciparum gametocytes in malaria nonexposed donors

  1997cited by this paper
• Inhibition of nitric oxide interrupts the accumulation of CD8+ T cells surrounding Plasmodium berghei-infected hepatocytes

  1997cited by this paper
• A protein particle vaccine containing multiple malaria epitopes

  1997cited by this paper
• Peptides naturally presented by MHC class I molecules.

  1993cited by this paper
• Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria.

  1991cited by this paper
• Human T cell recognition of polymorphic epitopes from malaria circumsporozoite protein.

  1989cited by this paper
• Human T cells recognize polymorphic and non‐polymorphic regions of the Plasmodium falciparum circumsporozoite protein.

  1988cited by this paper
• Role of T cells in preventing transmission of rodent malaria.

  1985cited by this paper
• Gamma-Globulin and Acquired Immunity to Human Malaria

  1961cited by this paper

• Unraveling an enhancer-silencer regulatory element showing epistatic interaction with a variant that escaped genome-wide association studies

  2025cites this paper
• Human responses to the DNA prime/chimpanzee adenovirus (ChAd63) boost vaccine identify CSP, AMA1 and TRAP MHC Class I-restricted epitopes

  2025cites this paper
• Leaky Vaccines: A Wicked Problem in Accelerated Vaccine Development

  2024cites this paper
• Vaccins imparfaits : Un problème épineux dans le développement accéléré des vaccins

  2024cites this paper
• Review on the applications of atomic force microscopy imaging in proteins.

  2022cites this paper
• Perturbations in the T cell receptor β repertoire during malaria infection in children: A preliminary study

  2022cites this paper
• Comparison of the impact of allelic polymorphisms in PfAMA1 on the induction of T Cell responses in high and low malaria endemic communities in Ghana

  2021cites this paper
• Functional Food for the Stimulation of the Immune System Against Malaria

  2021cites this paper
• Bioengineered Liver Cell Models of Hepatotropic Infections

  2021cites this paper
• Comparative analysis of the ex vivo IFN-gamma responses to CD8+ T cell epitopes within allelic forms of PfAMA1 in subjects with natural exposure to malaria

  2021cites this paper
• T Cell-Based Vaccines: Hope for Malaria Elimination

  2021cites this paper
• A Conserved TCRβ Signature Dominates a Highly Polyclonal T-Cell Expansion During the Acute Phase of a Murine Malaria Infection

  2020cites this paper
• Harnessing Cellular Immunity for Vaccination against Respiratory Viruses

  2020cites this paper
• Asymptomatic Malaria Infection Is Maintained by a Balanced Pro- and Anti-inflammatory Response

  2020cites this paper
• Identification of Plasmodium falciparum circumsporozoite protein-specific CD8+ T cell epitopes in a malaria exposed population

  2020cites this paper
• Resident Memory T Cells

  2020cites this paper
• Immune effector mechanisms in malaria: An update focusing on human immunity

  2019cites this paper
• Phenotypic Evidence of T Cell Exhaustion and Senescence During Symptomatic Plasmodium falciparum Malaria

  2019cites this paper